EUVIMEDEUVIMED entdecken
Open Access

Circulating Extracellular Vesicle MicroRNAs as Predictive Biomarkers for Kidney and Cardiovascular Events

Shunsuke Inaba iD, Takanori Hasegawa iD, Yuta Nakano iD, Shotaro Naito iD, Rena Suzukawa iD, Takaaki Koide, Hisateru Sekiya, Hisazumi Matsuki, Tamami Fujiki, Hiroaki Kikuchi iD, Yohei Arai iD, Yutaro Mori iD und 7 weitere

Journal of the American Heart Association · 06.01.2026 · 15 (1)

DOI: 10.1161/jaha.125.045148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 06.01.2026. Verfasst von Shunsuke Inaba und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Graduate School of Medical and Dental Sciences Institute of Science Tokyo Tokyo Japan. Hauptthemen laut MEDLINE: Extracellular Vesicles, Circulating MicroRNA, Cardiovascular Diseases, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease ( CKD ) leads to premature mortality from cardiovascular events before kidney replacement therapy. Despite recognition of syndromes like cardiorenal anemia and cardiovascular‐kidney‐metabolic, predictive models for kidney and cardiovascular outcomes remain inadequate. This study aimed to develop a minimally invasive, risk model using circulating small extracellular vesicle‐derived mi RNAs among patients with CKD .

Methods

A derivation cohort (n=36) underwent microarray‐based miRNA profiling, and a least absolute shrinkage and selection operator‐penalized Cox proportional hazards model was constructed. Validation was performed using TaqMan quantitative polymerase chain reaction in a cohort of 234 patients with CKD without kidney replacement therapy. The primary outcome was a ≥30% reduction in estimated glomerular filtration rate or progression to kidney replacement therapy. The secondary outcome included all‐cause mortality, kidney replacement therapy initiation, and major adverse cardiovascular events.

Results

In the derivation cohort, 36% of patients had hypertensive glomerulosclerosis as the underlying CKD cause, increasing to 48% in the validation cohort. Twenty‐three miRNAs were significantly downregulated in advanced CKD , associated with cellular senescence, FOXO (forkhead box, class O) signaling, and cell cycle pathways. From these, 3 miRNAs — hsa‐let‐7d‐5p , hsa‐ miR ‐24‐3p , and hsa‐ miR ‐126‐3p —were selected and integrated into the final risk score with cystatin C and urinary protein levels, following optimization in the validation cohort. Lower miRNA levels were linked to cardiovascular comorbidities and cardiorenal anemia syndrome. Over a median follow‐up of 39 and 59 months, 108 kidney events and 70 composite outcomes occurred. The model effectively predicted adverse outcomes across CKD causes, further stratifying risk within cardiovascular‐kidney‐metabolic stage classifications.

Conclusions

Circulating small extracellular vesicle‐derived miRNA profiles enable a noninvasive, longitudinally predictive model for adverse kidney and cardiovascular outcomes in CKD . This approach may improve early risk identification and clinical decision‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesCirculating MicroRNACardiovascular DiseasesRenal Insufficiency, ChronicMicroRNAsHumansMaleFemaleMiddle AgedAgedGlomerular Filtration RateRisk AssessmentBiomarkersRisk FactorsPrognosisPredictive Value of TestsDisease ProgressionGene Expression Profiling

Stichwörter der Autor:innen

biomarkercardiovascular‐kidney‐metabolic syndromechronic kidney diseaseextracellular vesiclesmicroRNA

Substanzen

Circulating MicroRNABiomarkersMicroRNAs

Autor:innen und Institutionen

  • Department of Nephrology, Graduate School of Medical and Dental Sciences Institute of Science Tokyo Tokyo Japan.
  • M&D Data Science Center, Institute of Integrated Research Institute of Science Tokyo Tokyo Japan.

ORCID-Profile: Shunsuke Inaba, Takanori Hasegawa, Yuta Nakano, Shotaro Naito, Rena Suzukawa, Hiroaki Kikuchi, Yohei Arai, Yutaro Mori, Fumiaki Ando, Takayasu Mori, Koichiro Susa, Eisei Sohara, Shintaro Mandai

Zitieren

APA

Inaba, S., Hasegawa, T., Nakano, Y., Naito, S., Suzukawa, R., Koide, T., Sekiya, H., Matsuki, H., Fujiki, T., Kikuchi, H., Arai, Y., Mori, Y., Ando, F., Mori, T., Susa, K., Iimori, S., Sohara, E., Uchida, S., & Mandai, S. (2026). Circulating Extracellular Vesicle MicroRNAs as Predictive Biomarkers for Kidney and Cardiovascular Events. Journal of the American Heart Association, 15(1). https://doi.org/10.1161/jaha.125.045148

Vancouver

Inaba S, Hasegawa T, Nakano Y, Naito S, Suzukawa R, Koide T, et al. Circulating Extracellular Vesicle MicroRNAs as Predictive Biomarkers for Kidney and Cardiovascular Events. Journal of the American Heart Association. 2026;15(1). doi:10.1161/jaha.125.045148

BibTeX
@article{Inaba2026,
  author = {Inaba, Shunsuke and Hasegawa, Takanori and Nakano, Yuta and Naito, Shotaro and Suzukawa, Rena and Koide, Takaaki and Sekiya, Hisateru and Matsuki, Hisazumi and Fujiki, Tamami and Kikuchi, Hiroaki and Arai, Yohei and Mori, Yutaro and Ando, Fumiaki and Mori, Takayasu and Susa, Koichiro and Iimori, Soichiro and Sohara, Eisei and Uchida, Shinichi and Mandai, Shintaro},
  title = {Circulating Extracellular Vesicle MicroRNAs as Predictive Biomarkers for Kidney and Cardiovascular Events},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1161/jaha.125.045148}
}
Kostenlos starten →